| Rubicon Research Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544578 |
NSE Symbol : RUBICON |
P/E(TTM) : 62.20 |
|
ISIN Demat : INE506V01022 |
Div & Yield% : 0.00 |
EPS(TTM) : 10.22 |
|
Book Value(₹) : 71.10 |
Market Cap(₹Cr) : 10,473.18 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Gross Sales | 336.47 | 278.03 | 254.90 | 273.27 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 336.47 | 278.03 | 254.90 | 273.27 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.51 | 1.44 | 2.82 | 2.56 |
| Total Income | 337.98 | 279.46 | 257.72 | 275.83 |
| Total Expenditure | 257.37 | 214.89 | 186.49 | 196.99 |
| PBIDT | 80.61 | 64.58 | 71.23 | 78.84 |
| Interest | 9.21 | 8.85 | 6.38 | 9.88 |
| PBDT | 71.41 | 55.73 | 64.85 | 68.96 |
| Depreciation | 9.78 | 8.30 | 7.32 | 8.20 |
| Tax | 19.12 | 10.05 | 15.30 | 14.52 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -3.30 | 2.23 | -0.65 | 0.09 |
| Reported Profit After Tax | 45.81 | 35.15 | 42.89 | 46.16 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 45.81 | 35.15 | 42.89 | 46.16 |
| EPS (Unit Curr.) | 2.97 | 2.28 | 2.82 | 2.99 |
| EPS (Adj) (Unit Curr.) | 2.97 | 2.28 | 2.82 | 2.99 |
| Calculated EPS (Unit Curr.) | 2.97 | 2.28 | 2.78 | 2.99 |
| Calculated EPS (Adj) (Unit Curr.) | 2.97 | 2.28 | 2.78 | 2.99 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.87 | 9.12 | 11.13 | 11.98 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.87 | 9.12 | 11.13 | 11.98 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.44 | 15.41 | 15.41 | 15.41 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.96 | 23.23 | 27.94 | 28.85 |
| PBDTM(%) | 21.22 | 20.04 | 25.44 | 25.24 |
| PATM(%) | 13.61 | 12.64 | 16.83 | 16.89 |